Regulatory and Industry Insights & Lessons Learned

Closing Plenary Session & Fireside Chat - Regulatory and Industry Insights & Lessons Learned Wrapping up the conference it is important to hear from regulatory leaders to help frame the strategy for the era ahead.  Lessons learned from organizations around the world will give individuals the most current insights for those difficult discussion back at your home base. 

• Facilitating Development of Advanced Therapies
  Raj K. Puri, MD, Director, Division of Cellular & Gene Therapies
  CBER, FDA  
• Industry and Regulatory Fireside Chat
  Raj K. Puri, MD, PhD, Director, Division of Cellular & Gene Therapies
  CBER, FDA
  Patricia Hughes, PhD, Branch Chief, Division of Microbiology Assessment
  CDER, FDA
  John Balchunas, Workforce Director National Institute for
  Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
  Lawrence Hill, CEO & VP Global Clinical Development
  Gan & Lee USA
  Maria Hoffman, Executive Director, Supply Chain Management
  Merck
• Closing Remarks & Adjourn
  Joseph Famulare, Conference Chair, VP Global Compliance & External Collaboration
  Genentech